232 related articles for article (PubMed ID: 24687169)
1. Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial.
Lexis CP; van der Horst IC; Lipsic E; Wieringa WG; de Boer RA; van den Heuvel AF; van der Werf HW; Schurer RA; Pundziute G; Tan ES; Nieuwland W; Willemsen HM; Dorhout B; Molmans BH; van der Horst-Schrivers AN; Wolffenbuttel BH; ter Horst GJ; van Rossum AC; Tijssen JG; Hillege HL; de Smet BJ; van der Harst P; van Veldhuisen DJ;
JAMA; 2014 Apr; 311(15):1526-35. PubMed ID: 24687169
[TBL] [Abstract][Full Text] [Related]
2. Metformin in non-diabetic patients presenting with ST elevation myocardial infarction: rationale and design of the glycometabolic intervention as adjunct to primary percutaneous intervention in ST elevation myocardial infarction (GIPS)-III trial.
Lexis CP; van der Horst IC; Lipsic E; van der Harst P; van der Horst-Schrivers AN; Wolffenbuttel BH; de Boer RA; van Rossum AC; van Veldhuisen DJ; de Smet BJ;
Cardiovasc Drugs Ther; 2012 Oct; 26(5):417-26. PubMed ID: 22968678
[TBL] [Abstract][Full Text] [Related]
3. Two-year follow-up of 4 months metformin treatment vs. placebo in ST-elevation myocardial infarction: data from the GIPS-III RCT.
Hartman MHT; Prins JKB; Schurer RAJ; Lipsic E; Lexis CPH; van der Horst-Schrivers ANA; van Veldhuisen DJ; van der Horst ICC; van der Harst P
Clin Res Cardiol; 2017 Dec; 106(12):939-946. PubMed ID: 28755285
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte telomere length and left ventricular function after acute ST-elevation myocardial infarction: data from the glycometabolic intervention as adjunct to primary coronary intervention in ST elevation myocardial infarction (GIPS-III) trial.
Haver VG; Hartman MH; Mateo Leach I; Lipsic E; Lexis CP; van Veldhuisen DJ; van Gilst WH; van der Horst IC; van der Harst P
Clin Res Cardiol; 2015 Oct; 104(10):812-21. PubMed ID: 25840550
[TBL] [Abstract][Full Text] [Related]
5. Effect of Metformin on Metabolites and Relation With Myocardial Infarct Size and Left Ventricular Ejection Fraction After Myocardial Infarction.
Eppinga RN; Kofink D; Dullaart RP; Dalmeijer GW; Lipsic E; van Veldhuisen DJ; van der Horst IC; Asselbergs FW; van der Harst P
Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28100626
[TBL] [Abstract][Full Text] [Related]
6. Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial.
Eppinga RN; Hartman MH; van Veldhuisen DJ; Lexis CP; Connelly MA; Lipsic E; van der Horst IC; van der Harst P; Dullaart RP
PLoS One; 2016; 11(1):e0145719. PubMed ID: 26808474
[TBL] [Abstract][Full Text] [Related]
7. Association of Circulating Ketone Bodies With Functional Outcomes After ST-Segment Elevation Myocardial Infarction.
de Koning MLY; Westenbrink BD; Assa S; Garcia E; Connelly MA; van Veldhuisen DJ; Dullaart RPF; Lipsic E; van der Harst P
J Am Coll Cardiol; 2021 Oct; 78(14):1421-1432. PubMed ID: 34593124
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Metformin on Diastolic Function in Patients Presenting with ST-Elevation Myocardial Infarction.
Al Ali L; Hartman MT; Lexis CP; Hummel YM; Lipsic E; van Melle JP; van Veldhuisen DJ; Voors AA; van der Horst IC; van der Harst P
PLoS One; 2016; 11(12):e0168340. PubMed ID: 27977774
[TBL] [Abstract][Full Text] [Related]
9. [Metformin and left ventricular remodeling after acute myocardial infarction: molecular mechanisms and clinical implications].
Paneni F; Costantino S; Cosentino F
G Ital Cardiol (Rome); 2015 Apr; 16(4):225-31. PubMed ID: 25959758
[TBL] [Abstract][Full Text] [Related]
10. Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.
Traverse JH; Henry TD; Pepine CJ; Willerson JT; Zhao DX; Ellis SG; Forder JR; Anderson RD; Hatzopoulos AK; Penn MS; Perin EC; Chambers J; Baran KW; Raveendran G; Lambert C; Lerman A; Simon DI; Vaughan DE; Lai D; Gee AP; Taylor DA; Cogle CR; Thomas JD; Olson RE; Bowman S; Francescon J; Geither C; Handberg E; Kappenman C; Westbrook L; Piller LB; Simpson LM; Baraniuk S; Loghin C; Aguilar D; Richman S; Zierold C; Spoon DB; Bettencourt J; Sayre SL; Vojvodic RW; Skarlatos SI; Gordon DJ; Ebert RF; Kwak M; Moyé LA; Simari RD;
JAMA; 2012 Dec; 308(22):2380-9. PubMed ID: 23129008
[TBL] [Abstract][Full Text] [Related]
11. Effect of Levothyroxine on Left Ventricular Ejection Fraction in Patients With Subclinical Hypothyroidism and Acute Myocardial Infarction: A Randomized Clinical Trial.
Jabbar A; Ingoe L; Junejo S; Carey P; Addison C; Thomas H; Parikh JD; Austin D; Hollingsworth KG; Stocken DD; Pearce SHS; Greenwood JP; Zaman A; Razvi S
JAMA; 2020 Jul; 324(3):249-258. PubMed ID: 32692386
[TBL] [Abstract][Full Text] [Related]
12. Calcium/Calmodulin-Dependent Protein Kinase II Delta Inhibition and Ventricular Remodeling After Myocardial Infarction: A Randomized Clinical Trial.
Boyle AJ; Schultz C; Selvanayagam JB; Moir S; Kovacs R; Dib N; Zlotnick D; Al-Omary M; Sugito S; Selvarajah A; Collins N; McLachlan G
JAMA Cardiol; 2021 Jul; 6(7):762-768. PubMed ID: 33851966
[TBL] [Abstract][Full Text] [Related]
13. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.
Ezekowitz JA; Armstrong PW; Granger CB; Theroux P; Stebbins A; Kim RJ; Patel MR
Am Heart J; 2010 Aug; 160(2):272-8. PubMed ID: 20691832
[TBL] [Abstract][Full Text] [Related]
14. Randomized Control of Sympathetic Drive With Continuous Intravenous Esmolol in Patients With Acute ST-Segment Elevation Myocardial Infarction: The BEtA-Blocker Therapy in Acute Myocardial Infarction (BEAT-AMI) Trial.
Er F; Dahlem KM; Nia AM; Erdmann E; Waltenberger J; Hellmich M; Kuhr K; Le MT; Herrfurth T; Taghiyev Z; Biesenbach E; Yüksel D; Eran-Ergöknil A; Vanezi M; Caglayan E; Gassanov N
JACC Cardiovasc Interv; 2016 Feb; 9(3):231-240. PubMed ID: 26847114
[TBL] [Abstract][Full Text] [Related]
15. [Effect of left ventricular ejection fraction on clinical long-term follow-up outcomes in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
Wang CH; Xie XJ; Fang Q; Zhang SY; Fang ZJ; Jiang XF; Xie HZ; Liu ZY; Shen ZJ
Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):265-8. PubMed ID: 21418873
[TBL] [Abstract][Full Text] [Related]
16. Effects of Compound Danshen Dripping Pills on Ventricular Remodeling and Cardiac Function after Acute Anterior Wall ST-Segment Elevation Myocardial Infarction (CODE-AAMI): Protocol for a Randomized Placebo-Controlled Trial.
Wu YJ; Deng B; Wang SB; Qiao R; Zhang XW; Lu Y; Wang L; Gu SZ; Zhang YQ; Li KQ; Yu ZL; Wu LX; Zhao SB; Zhou SL; Yang Y; Wang LS
Chin J Integr Med; 2023 Dec; 29(12):1059-1065. PubMed ID: 37656413
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
[TBL] [Abstract][Full Text] [Related]
18. Effect of Metformin on Renal Function After Primary Percutaneous Coronary Intervention in Patients Without Diabetes Presenting with ST-elevation Myocardial Infarction: Data from the GIPS-III Trial.
Posma RA; Lexis CP; Lipsic E; Nijsten MW; Damman K; Touw DJ; van Veldhuisen DJ; van der Harst P; van der Horst IC
Cardiovasc Drugs Ther; 2015; 29(5):451-9. PubMed ID: 27656713
[TBL] [Abstract][Full Text] [Related]
19. Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.
Margulies KB; Hernandez AF; Redfield MM; Givertz MM; Oliveira GH; Cole R; Mann DL; Whellan DJ; Kiernan MS; Felker GM; McNulty SE; Anstrom KJ; Shah MR; Braunwald E; Cappola TP;
JAMA; 2016 Aug; 316(5):500-8. PubMed ID: 27483064
[TBL] [Abstract][Full Text] [Related]
20. Metformin and Myocardial Injury in Patients With Diabetes and ST-Segment Elevation Myocardial Infarction: A Propensity Score Matched Analysis.
Basnet S; Kozikowski A; Makaryus AN; Pekmezaris R; Zeltser R; Akerman M; Lesser M; Wolf-Klein G
J Am Heart Assoc; 2015 Oct; 4(10):e002314. PubMed ID: 26494519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
